Yoga for Back Pain in Adolescent Scoliosis
Launched by JOHNS HOPKINS UNIVERSITY · Jan 29, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of yoga on adolescents with Adolescent Idiopathic Scoliosis (AIS), a condition that causes an abnormal curvature of the spine and can lead to back pain and other challenges. The researchers want to see if adding a structured yoga program to the usual treatments can improve both physical and emotional well-being for these patients. This is particularly important because many adolescents with AIS do not need surgery and are looking for ways to manage their pain without relying on medications, especially opioids.
To participate in the trial, individuals must be between 10 and 20 years old, have a specific degree of spinal curvature (greater than 25 degrees), and be experiencing back pain. Participants will be divided into two groups: one will continue with standard care, while the other will also take part in the yoga program. Throughout the trial, researchers will track various health outcomes, including pain levels, sleep quality, and overall well-being. This study aims to provide new insights into non-surgical management options for AIS, potentially leading to better quality of life for young patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Non-operatively treated AIS patients at Johns Hopkins Hospital with back pain who are candidates for physical therapy.
- • Cobb angle: greater than 25 degrees,
- • Visual Analog Scale (VAS) Pain score greater than 41/0
- • Braced and Unbraced Patients
- Exclusion Criteria:
- • Scoliosis due to causes other than AIS.
- • AIS patients who have undergone surgery for scoliosis or back pain
- • Age less than 10 years of age or greater than 20 years of age
- • Unable to access zoom on any electronic device
About Johns Hopkins University
Johns Hopkins University, a prestigious research institution located in Baltimore, Maryland, is renowned for its commitment to advancing medical science and public health through innovative clinical trials. With a rich history of groundbreaking research and a multidisciplinary approach, the university's clinical trial initiatives focus on translating scientific discoveries into effective treatments and interventions. Leveraging state-of-the-art facilities and a collaborative network of experts, Johns Hopkins University conducts rigorous clinical studies that aim to improve patient outcomes and address critical health challenges. Its dedication to ethical standards and participant safety underscores its role as a leader in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Baltimore, Maryland, United States
Patients applied
Trial Officials
Paul Sponseller, MD
Principal Investigator
Johns Hopkins School of Medicine
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported